[go: up one dir, main page]

MEP88408A - Pharmaceutical compositions containing oligosaccharides and preparation thereof - Google Patents

Pharmaceutical compositions containing oligosaccharides and preparation thereof

Info

Publication number
MEP88408A
MEP88408A MEP-884/08A MEP88408A MEP88408A ME P88408 A MEP88408 A ME P88408A ME P88408 A MEP88408 A ME P88408A ME P88408 A MEP88408 A ME P88408A
Authority
ME
Montenegro
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
containing oligosaccharides
oligosaccharides
Prior art date
Application number
MEP-884/08A
Other languages
Bosnian (bs)
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of MEP88408A publication Critical patent/MEP88408A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)

Abstract

Ovaj pronalazak se odnosi na farmaceutske smješe koje kao akti vni princip sadrže oligosaharid formule: Ili smješu ovih oligosaharida, zati m na nove oligosaharid fomule (I), njihove smješe i postupke njihovog dobijanja.The present invention relates to pharmaceutical compositions which contain as active principle an oligosaccharide of the formula: Or a mixture of these oligosaccharides, then to the novel oligosaccharide formulas (I), mixtures thereof and processes for their preparation.

MEP-884/08A 2000-03-28 2001-03-26 Pharmaceutical compositions containing oligosaccharides and preparation thereof MEP88408A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003910A FR2807043B1 (en) 2000-03-28 2000-03-28 PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION
PCT/FR2001/000903 WO2001072762A1 (en) 2000-03-28 2001-03-26 Pharmaceutical compositions containing oligosaccharides and preparation thereof

Publications (1)

Publication Number Publication Date
MEP88408A true MEP88408A (en) 2011-12-20

Family

ID=8848572

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-884/08A MEP88408A (en) 2000-03-28 2001-03-26 Pharmaceutical compositions containing oligosaccharides and preparation thereof

Country Status (26)

Country Link
EP (1) EP1272499B1 (en)
JP (1) JP2003529570A (en)
KR (1) KR20030001394A (en)
CN (1) CN1183149C (en)
AR (1) AR034251A1 (en)
AT (1) ATE290543T1 (en)
AU (1) AU782713B2 (en)
BR (1) BR0109617A (en)
CA (1) CA2403906A1 (en)
DE (1) DE60109279T2 (en)
EA (1) EA004768B1 (en)
EE (1) EE200200551A (en)
ES (1) ES2236206T3 (en)
FR (1) FR2807043B1 (en)
HU (1) HUP0300330A3 (en)
IL (1) IL151832A0 (en)
ME (1) MEP88408A (en)
MX (1) MXPA02009455A (en)
NO (1) NO20024590D0 (en)
NZ (1) NZ521558A (en)
PL (1) PL204419B1 (en)
PT (1) PT1272499E (en)
SK (1) SK286745B6 (en)
WO (1) WO2001072762A1 (en)
YU (1) YU72802A (en)
ZA (1) ZA200207707B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
FR2845686B1 (en) * 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (en) * 2003-07-24 2005-08-26 Aventis Pharma Sa MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
JP5116071B2 (en) * 2005-07-20 2013-01-09 帝國製薬株式会社 Use of anti-neuropathic pain effects of D-allose and D-psicose
JP5137118B2 (en) 2005-08-30 2013-02-06 国立大学法人高知大学 Universal base
EP3418287A1 (en) * 2017-06-21 2018-12-26 Universität für Bodenkultur Wien Chemical release of asparaginelinked glycans
CN115317507A (en) * 2022-09-19 2022-11-11 中国科学院海洋研究所 Application of Low Molecular Weight Fucoidan Sulfate in the Preparation of Anti-ADHD Drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
IL151832A0 (en) 2003-04-10
HK1056564A1 (en) 2004-02-20
CN1426419A (en) 2003-06-25
PT1272499E (en) 2005-06-30
EA004768B1 (en) 2004-08-26
JP2003529570A (en) 2003-10-07
ZA200207707B (en) 2003-12-24
FR2807043B1 (en) 2002-11-22
NO20024590L (en) 2002-09-25
HUP0300330A2 (en) 2003-06-28
KR20030001394A (en) 2003-01-06
SK13932002A3 (en) 2003-06-03
EE200200551A (en) 2004-04-15
PL357301A1 (en) 2004-07-26
ATE290543T1 (en) 2005-03-15
CN1183149C (en) 2005-01-05
NO20024590D0 (en) 2002-09-25
SK286745B6 (en) 2009-04-06
AU782713B2 (en) 2005-08-25
YU72802A (en) 2006-01-16
EP1272499A1 (en) 2003-01-08
CA2403906A1 (en) 2001-10-04
ES2236206T3 (en) 2005-07-16
WO2001072762A1 (en) 2001-10-04
AU4663901A (en) 2001-10-08
PL204419B1 (en) 2010-01-29
HUP0300330A3 (en) 2003-09-29
FR2807043A1 (en) 2001-10-05
MXPA02009455A (en) 2003-02-12
DE60109279T2 (en) 2006-04-13
EP1272499B1 (en) 2005-03-09
AR034251A1 (en) 2004-02-18
NZ521558A (en) 2005-10-28
BR0109617A (en) 2003-02-04
EA200201024A1 (en) 2003-02-27
DE60109279D1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
MEP9509A (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
YU56995A (en) ONLY DERIVED INDOLA
BR0108678A (en) New compounds
TR199901578T2 (en) Clarithromycin form 0 crystals
GEP20094676B (en) Piperidine compounds and pharmaceutical compositions containing them
ATE286500T1 (en) 1,2,3,4-TETRAHYDROISOCINOLINE DERIVATIVES
ATE409048T1 (en) PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES
MX9201068A (en) DERIVATIVES OF UREA CYCLICS, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
IS6658A (en) New compounds
BRPI0416276A (en) macrocyclic lactames and pharmaceutical use thereof
MY115339A (en) Compositions containing micronized nebivolol
DE60112330D1 (en) Pyrazolopyridinderivate
EP1340755A4 (en) Anti-helicobacterial agents
ES2036926A1 (en) (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists.
MEP88408A (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
BR0211030A (en) Pyrrolidine oxadiazole derivative, use of a pyrrolidine oxadiazole derivative, pharmaceutical composition containing at least one pyrrolidine oxadiazole derivative, method for preparing a pyrrolidine oxadiazole compound
TR200401052T4 (en) New compounds
CA2107485A1 (en) Ellipticin derivatives, their preparation process and pharmaceutical compositions containing them
SE9904128D0 (en) Novel compounds
YU37597A (en) New pyranosid derivatives
YU4497A (en) Novel heteroaryl - oxazolidinones
HUP0004701A2 (en) New salts of desloratadine, pharmaceutical compositions containing them and process for the preparation thereof
DK1047664T3 (en) Tricyclic compounds, processes for their preparation and pharmaceutical compositions containing them
CA2165618A1 (en) Tricyclic oxime ethers; process for preparing the same and pharmaceutical compositions containing them
EA200000261A3 (en) New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them